FUSION PHARMACEUTICALS INC (FUSN) Stock Analyst Earnings Estimates
NASDAQ:FUSN - Nasdaq - CA36118A1003 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.44M | 1.46M 1.39% | 2.068M 41.64% | 394.74K -80.91% | 409.316K 3.69% | 8.907M 2,076.07% | 582.277K -93.46% | 51.021M 8,662.32% | 335.49M 557.55% | 709.06M 111.35% | 1.136B 60.21% | |
| EBITDA YoY % growth | -81.39M -117.27% | -87.12M -7.04% | -97.887M -12.36% | -130.068M -32.88% | -151.818M -16.72% | -139.698M 7.98% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -82.02M -116.18% | -88.03M -7.33% | -99.232M -12.73% | -128.224M -29.22% | -142.924M -11.46% | -152.908M -6.99% | -185.317M -21.19% | -133.683M 27.86% | 81.185M 160.73% | 432.77M 433.07% | 718.63M 66.05% | |
| Operating Margin | -5,695.83% | -6,029.45% | -4,798.45% | -32,483.07% | -34,917.85% | -1,716.72% | -31,826.22% | -262.02% | 24.20% | 61.03% | 63.26% | |
| EPS YoY % growth | -1.90 31.89% | -2.00 -5.26% | -1.47 26.50% | -1.48 -0.46% | -1.71 -15.94% | -1.74 -1.67% | -1.71 1.56% | -1.07 37.35% | 1.19 211.16% | 2.94 146.44% | 4.41 50.06% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 3.82% | -0.37 -49.60% | -0.38 3.41% | -0.44 -10.50% | -0.45 -22.79% | -0.47 -25.45% | -0.48 -26.36% | -0.48 -8.46% | -0.48 -6.82% | -0.49 -4.35% | -0.50 -5.00% |
| Revenue Q2Q % growth | 162.517K 377.99% | 155.723K -92.24% | 165.444K | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | -33.711M -29.16% | -33.711M -83.11% | -33.711M -25.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -31.391M -17.53% | -31.885M -64.44% | -32.844M -16.16% | -35.7M 0.45% | -36.21M -15.35% | -39.27M -23.16% | -39.78M -21.12% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.40 11.11% | -0.38 | -0.02 | -5.51% |
| Q4 2023 Q2Q % growth | -0.39 29.09% | -0.34 | -0.05 | -13.32% |
| Q3 2023 Q2Q % growth | -0.25 54.55% | -0.41 | 0.16 | 38.59% |
| Q2 2023 Q2Q % growth | -0.38 13.64% | -0.40 | 0.02 | 4.20% |
| Q1 2023 Q2Q % growth | -0.45 2.17% | -0.32 | -0.13 | -38.95% |
| Q4 2022 Q2Q % growth | -0.55 -37.50% | -0.57 | 0.02 | 3.02% |
| Q3 2022 Q2Q % growth | -0.55 -22.22% | -0.51 | -0.04 | -7.84% |
| Q2 2022 Q2Q % growth | -0.44 30.16% | -0.54 | 0.10 | 18.99% |
| Q1 2022 Q2Q % growth | -0.46 -9.52% | -0.49 | 0.03 | 6.05% |
| Q4 2021 Q2Q % growth | -0.40 -25.00% | -0.48 | 0.08 | 15.97% |
| Q3 2021 Q2Q % growth | -0.45 -87.50% | -0.61 | 0.16 | 26.22% |
| Q2 2021 Q2Q % growth | -0.63 78.93% | -0.40 | -0.23 | -58.37% |
| Q1 2021 Q2Q % growth | -0.42 | -0.30 | -0.12 | -40.38% |
| Q4 2020 Q2Q % growth | -0.32 | -0.20 | -0.12 | -62.97% |
| Q3 2020 Q2Q % growth | -0.24 | -0.14 | -0.10 | -68.07% |
| Q2 2020 Q2Q % growth | -2.99 | -0.51 | -2.48 | -486.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | 154.867K | -154.867K | -100.00% |
| Q4 2023 Q2Q % growth | -100.00% | 418.098K | -418.098K | -100.00% |
| Q3 2023 Q2Q % growth | 2.006M 1,080.00% | 97.471K | 1.909M | 1,958.04% |
| Q2 2023 Q2Q % growth | 34K -94.04% | 86.068K | -52.068K | -60.50% |
| Q1 2023 Q2Q % growth | 28K -95.25% | 8.743M | -8.715M | -99.68% |
| Q4 2022 Q2Q % growth | 140K -76.27% | 17.34K | 122.66K | 707.38% |
| Q3 2022 Q2Q % growth | 170K -48.48% | 102K | 68K | 66.67% |
| Q2 2022 Q2Q % growth | 570K 9.62% | 140.25K | 429.75K | 306.42% |
| Q1 2022 Q2Q % growth | 590K | 1.148M | -558K | -48.61% |
| Q4 2020 Q2Q % growth | 3.4M | -3.4M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.22% | -5.78% | -1.56% | -4.77% |
| Revenue | 0% | 457.68% | -25.29% | -27.93% |